Eastern Capital LTD 13D/13G Filings for Cyclacel Pharmaceuticals, Inc. (CYCC)

Eastern Capital LTD 13D and 13G filings for Cyclacel Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2020-05-05
5:23 pm
Purchase
2020-04-24 13G Cyclacel Pharmaceuticals, Inc.
CYCC
Eastern Capital LTD 7,224
3.900%
7,224increase
(New Position)
Filing